IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 144 filers reported holding IMMUNOMEDICS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $222,000 | -31.7% | 16,477 | +7.2% | 0.01% | -7.1% |
| Q4 2019 | $325,000 | +64.1% | 15,377 | +2.8% | 0.01% | +55.6% |
| Q3 2019 | $198,000 | -4.3% | 14,953 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $207,000 | -11.5% | 14,953 | +22.6% | 0.01% | -18.2% |
| Q1 2019 | $234,000 | +40.1% | 12,193 | +4.3% | 0.01% | +22.2% |
| Q4 2018 | $167,000 | -31.6% | 11,693 | 0.0% | 0.01% | -18.2% |
| Q3 2018 | $244,000 | -6.2% | 11,693 | +6.4% | 0.01% | -15.4% |
| Q2 2018 | $260,000 | +104.7% | 10,988 | +26.1% | 0.01% | +116.7% |
| Q1 2018 | $127,000 | -4.5% | 8,714 | +6.1% | 0.01% | 0.0% |
| Q4 2017 | $133,000 | +29.1% | 8,214 | 0.0% | 0.01% | +20.0% |
| Q3 2017 | $103,000 | +41.1% | 8,214 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $73,000 | +65.9% | 8,214 | +20.5% | 0.00% | +100.0% |
| Q1 2017 | $44,000 | – | 6,814 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |